Pharmaceutical Industry Trends & News - Pharmaceutical Technology

News

Eli Lilly raises 2026 outlook again as Q2 soars past estimates

Reporting 91% growth for Mounjaro, Lilly widened the gap to cardiometabolic rival Novo Nordisk.

Robert Barrie

News

What is ‘Premium Content’ on Pharmaceutical Technology?

News

Alteogen signs $365m Hybrozyme licensing deal with pharma company

Salong Debbarma

News

Schrödinger and BMS expand partnership to deploy AI for drug discovery

News

Novo Nordisk not currently in a position to pursue large-scale M&A, CEO says

PremiumFeatures

Orexin receptor agonists set to propel narcolepsy treatment into a new era

News

Mironid banks $46m in Series B to take rare kidney disease drug closer to clinic

News

AsymBio to secure $184m to support growth in biologics manufacturing

Analysis

Comment

Rethinking sterile product development for manufacturing success

PremiumAnalyst Comment

What will health and social care look like under Andy Burnham?

GlobalData Healthcare

Features

Boosting CGT access: a global consideration with wide-spanning benefits

Annabel Kartal Allen

Analyst Comment

European drug manufacturers under threat from proposed US supply chain bill

GlobalData Healthcare

Themes

Partner Content

Industry partnership will determine the success of the transition to low-GWP pMDIs

With regulatory conditions tightening around climate impact and environmental persistence of medical propellants, HFA-152a is a practical route to maintain clinical performance, patient outcomes and supply continuity of inhalers. However,...

More themes

News

Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory

Partner Content

Turning AI skeptics into AI advocates through high-integrity data

Partner Content

Keeping pace with generative AI in pharmaceutical and healthcare organisations

Analyst Comment

Pharma Meets AI Conference 2026: Key barriers to scaling AI in drug development

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Q2 2026 CRO Activity and Intel Report

$1870.00

Pharma M&A Deals H1 2026 - Top Themes: Strategic Intelligence

$495.00

Diabetic Macular Edema in Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

$17995.00

Type 2 Diabetes (T2D): Epidemiology Forecast to 2035

$9995.00

Epilepsy (Adults) in Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

$17995.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

What is ‘Premium Content’ on Pharmaceutical Technology?

Alteogen signs $365m Hybrozyme licensing deal with pharma company

Schrödinger and BMS expand partnership to deploy AI for drug discovery

Novo Nordisk not currently in a position to pursue large-scale M&A, CEO says

Orexin receptor agonists set to propel narcolepsy treatment into a new era

Mironid banks $46m in Series B to take rare kidney disease drug closer to clinic

AsymBio to secure $184m to support growth in biologics manufacturing

Rethinking sterile product development for manufacturing success

What will health and social care look like under Andy Burnham?

Boosting CGT access: a global consideration with wide-spanning benefits

European drug manufacturers under threat from proposed US supply chain bill

Industry partnership will determine the success of the transition to low-GWP pMDIs

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

Q2 2026 CRO Activity and Intel Report

Pharma M&A Deals H1 2026 - Top Themes: Strategic Intelligence

Diabetic Macular Edema in Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Type 2 Diabetes (T2D): Epidemiology Forecast to 2035

Epilepsy (Adults) in Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

Q2 2026 CRO Activity and Intel Report

Pharma M&A Deals H1 2026 - Top Themes: Strategic Intelligence

Diabetic Macular Edema in Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Type 2 Diabetes (T2D): Epidemiology Forecast to 2035

Epilepsy (Adults) in Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing